AI assistant
Vericel Corp — Director's Dealing 2022
Mar 11, 2022
31799_dirs_2022-03-11_173fc069-8246-42e5-8172-64da2d45cd57.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2022-02-16
Reporting Person: SIEGAL JONATHAN (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $48.80 | 2031-09-30 | Common Stock (56875) | Direct | |
| Restricted Stock Unit | $ | Common Stock (3750) | Direct |
Footnotes
F1: These options began vesting on September 30, 2021. On the first anniversary of the date of grant, September 30, 2022, 25% of the options shall vest and become exercisable, with the remaining 75% vesting in equal quarterly installments over three (3) years thereafter.
F2: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
F3: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on September 30, 2022. The remaining RSUs will vest in annual installments on September 30, 2023, September 30, 2024, and September 30, 2025, respectively.
F4: No expiration date for this type of award.